DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.7299
-0.1095 (-13.04%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close0.8394
Open0.8394
Bid0.5171 x 2900
Ask0.8243 x 800
Day's Range0.7200 - 0.8394
52 Week Range0.6810 - 2.6900
Volume41,457
Avg. Volume79,179
Market Cap18.931M
Beta (3Y Monthly)-0.58
PE Ratio (TTM)N/A
EPS (TTM)-0.9490
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.50
Trade prices are not sourced from all markets
  • DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider
    PR Newswire3 days ago

    DarioHealth to Offer Diabetes Content and Coaching to Patients in Canada in Collaboration With LMC Healthcare, Canada's Largest Diabetes and Endocrinology Specialist Care Provider

    CAESAREA, Israel, Dec. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Toronto-based LMC Healthcare, Canada's largest specialist care provider in diabetes and endocrinology, will work with Dario who will provide digital content and coaching services  across Canada for patients with diabetes. LMC has 11 clinics and 19 clinical research sites that provide care to over 39,000 patients with diabetes in Canada.

  • DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy
    PR Newswirelast month

    DarioHealth's Diabetes Digital Health Solution Now Available at Best Buy

    CAESAREA, Israel, Nov. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that the Dario Blood Glucose Monitor has been included in Best Buy's growing portfolio of digital healthcare services and products. The Dario Blood Glucose Monitor is part of DarioHealth's complete platform, which includes the Dario App and DarioEngage patient management system.

  • DarioHealth Reports Third Quarter 2018 Results
    PR Newswirelast month

    DarioHealth Reports Third Quarter 2018 Results

    - Earnings and business update call scheduled for 9:00 am ET today - Revenues in first 9 months grow to $5.7 million , a 58% increase year over year - Q3 revenues grow to $1.88 million , a 37% increase ...

  • DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains
    PR Newswirelast month

    DarioHealth's Digital Diabetes Platform to be Made Available to 4.6 Million Customers at Giant Eagle, One of America's Largest Supermarket Chains

    Millions of Customers Will Be Able to Sign Up for Online Education and Rewards through the DarioHealth Blood Glucose Monitoring System and Smartphone Application. CAESAREA, Israel, Nov. 12, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has signed an agreement for the rollout of a Digital Diabetes Education and Rewards Program, powered by Dario, to Giant Eagle's consumers through the pharmacy's 214 locations. Giant Eagle is ranked among the top 40 on Forbes magazine's list of largest private corporations in the U.S. It is one of the country's largest food retailers and distributors with approximately $8.9 billion in annual sales.

  • DarioHealth to Host Third Quarter 2018 Conference Call on November 13, 2018
    PR Newswirelast month

    DarioHealth to Host Third Quarter 2018 Conference Call on November 13, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , Nov. 6, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Award-winning Dario App and DarioEngage Patient Coaching Platform
    PR Newswire2 months ago

    DarioHealth Launches Integrated Diabetes Digital Health Solution Including Version 4.1 of Its Award-winning Dario App and DarioEngage Patient Coaching Platform

    CAESAREA , Israel, Oct. 25, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today the launch of version 4.1 of its award-winning Dario® App for the Dario Blood Glucose Monitoring System, part of the DarioHealth digital diabetes data management platform. "The very compelling clinical data we presented at the American Diabetes Association (ADA) in June made it clear that the combination of long term use of the Dario Blood Glucose Monitoring System and higher levels of user engagement results in sustainable user behavior changes and associated positive clinical outcomes.

  • DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max
    PR Newswire2 months ago

    DarioHealth's Digital Health Blood Glucose Monitoring System Compatible With New iPhone XS and XS Max

    CAESAREA, Israel, Oct. 23, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its Dario LC™ Blood Glucose Monitoring System, which enables the use of the Dario App, is  compatible with the iPhone XS and iPhone XS Max, both of which were launched on September 21, 2018. "Compatibility with the iPhone XS and XS Max further extends the market reach not only of our Dario™ Blood Glucose Monitoring System and Dario App, it also increases the value of our DarioEngage platform for healthcare providers and employers who are looking for a patient coaching platform that seamlessly integrates with the patient's mobile phone for real-time data and communication," stated Erez Raphael, Chief Executive Officer of DarioHealth.

  • DarioHealth Appoints Glen D. Moller, Healthcare Executive, Investor and Former CEO of ArroHealth, to Its Board of Directors
    PR Newswire2 months ago

    DarioHealth Appoints Glen D. Moller, Healthcare Executive, Investor and Former CEO of ArroHealth, to Its Board of Directors

    CAESAREA, Israel, Oct. 18, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Glen Moller has joined the Company's Board of Directors. Mr. Moller is a highly regarded healthcare executive with a 25-year career leading healthcare and technology businesses, including a background in managed care and in technology enabled health services.

  • DarioHealth to Host Investor Conference Call on October 4, 2018
    PR Newswire3 months ago

    DarioHealth to Host Investor Conference Call on October 4, 2018

    Call to review recent fundraise, expected accelerated growth, and introduce new President and new Chairman CAESAREA, Israel , Sept. 20, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading ...

  • DarioHealth Closes on $10,345,000 Through Private Placement Offering
    PR Newswire3 months ago

    DarioHealth Closes on $10,345,000 Through Private Placement Offering

    CAESAREA, Israel, Sept. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series D convertible preferred stock.

  • DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer
    PR Newswire3 months ago

    DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer

    CAESAREA, Israel, Sept. 5, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Olivier Jarry, a prominent global life sciences and consumer health executive, has joined the Company as President and Chief Commercial Officer. Mr. Jarry brings to DarioHealth more than 30 years of experience improving health and living standards throughout Western and Eastern Europe, the Americas and Asia.

  • DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management
    PR Newswire4 months ago

    DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management

    CAESAREA, Israel, Aug. 22, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health, a provider of integrative health coaching for individuals living with cystic fibrosis, to pilot the DarioEngage platform for the management of cystic fibrosis related diabetes (CFRD). CFRD is a unique from of diabetes that occurs in a subset of the estimated 30,000 Americans and 70,000 people worldwide living with cystic fibrosis.

  • DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore
    PR Newswire4 months ago

    DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore

    CAESAREA, Israel, Aug. 15, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Association of Diabetes Educators (AADE) annual conference at booth #348 on August 17-20, 2018 in Baltimore, Maryland. The AADE is a professional membership organization dedicated to improving diabetes care through innovative education, management, and support with more than 14,000 members including nurses, dietitians, pharmacists, and exercise specialists.

  • DarioHealth Reports Second Quarter 2018 Results
    PR Newswire4 months ago

    DarioHealth Reports Second Quarter 2018 Results

    - Record Q2 2018 revenue of $2.06 million marks 70% growth year over year - Sequential quarterly growth of 17% - Cash burn reduced by 27% from previous quarter NEW YORK and CAESAREA, Israel , Aug. 9, 2018 ...

  • ACCESSWIRE4 months ago

    DarioHealth Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2018 / DarioHealth Corp. (NASDAQ: DRIO ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 9:00 AM Eastern Time. ...

  • DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
    PR Newswire4 months ago

    DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , Aug. 1, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
    PR Newswire5 months ago

    DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , July 31, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes
    PR Newswire5 months ago

    DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes

    CAESAREA, Israel, July 25, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that following new data presented at the American Diabetes Association (ADA) on June 25, 2018 showing long-term sustainable clinical results, the Company has launched new product offerings and enhancements to promote the long-term use of its digital health platform. DarioHealth recently announced very compelling data from over 17,000 people who used its integrated digital health solution in 2017.

  • DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance
    PR Newswire5 months ago

    DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance

    CAESAREA, Israel, July 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled "Using real-time data to feed predictive care models for diabetes management." The interview covers topics including DarioHealth's position and strategy in the digital health market, as well as industry trends and a look at how users integrate digital health technologies into their daily lives to create measurable health benefits.

  • DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board
    PR Newswire5 months ago

    DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board

    CAESAREA, Israel, July 9, 2018 /PRNewswire/ --– DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. Mr. Shaked is a partner at Sequoia Capital, a world leading venture capital firm.

  • PR Newswire6 months ago

    DarioHealth Presents New Data at American Diabetes Association's 78th Scientific Sessions on June 25, 2018

    CAESAREA, Israel, June 25, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today reported new data at the American Diabetes Association's (ADA) 78th Scientific Sessions which takes place in Orlando, Florida from June 22-26, 2018. On Monday June 25, 2018 from 12:00 pm – 1:00pm ET, DarioHealth's Head of Commercialization for North America, JC Muyl, is delivering three poster presentations.

  • DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018
    PR Newswire6 months ago

    DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018

    NEW YORK and CAESAREA, Israel , June 21, 2018 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced JC Muyl, the Company's ...

  • DarioHealth Set to Join Russell Microcap® Index Effective June 25, 2018
    PR Newswire6 months ago

    DarioHealth Set to Join Russell Microcap® Index Effective June 25, 2018

    NEW YORK and CAESAREA, Israel, June 19, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its stock will be added to the Russell Microcap® Index, effective at market open on Monday, June 25, 2018. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attributes.

  • DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance
    PR Newswire6 months ago

    DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance

    DarioHealth Reveals First Indication of U.S. Market Opportunity NEW YORK and CAESAREA, Israel , June 7, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with ...

  • PR Newswire7 months ago

    DarioHealth to Present at Chardan's Digital Health Conference

    Presentation to be Given by Erez Raphael, Chairman and CEO of DarioHealth SAN FRANCISCO , May 21, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile ...